Dissecting the Anti-Inflammatory Effects of Viscum album: Inhibition of Cytokine-Induced Expression of Cyclo-Oxygenase-2 and Secretion of Prostaglandin E2

Reports unraveling the beneficial effects of Viscum album (VA) preparations as complementary therapies for cancer have increasingly revealed the underlying molecular and cellular mechanisms, which encompass cytotoxic properties, induction of apoptosis, inhibition of angiogenesis and several other immunomodulatory mechanisms. In addition to their propitious relevance to cancer therapy, VA preparations are also relevant for the treatment of several inflammatory pathologies. In view of the intricate association of inflammation and cancer and the fact that several anti-tumor phytotherapeutics exert potent anti-inflammatory effects, we believe that an anti-inflammatory effect is responsible for the therapeutic benefits of VA preparations. One of the underlying molecular mechanisms of this inflammatory response is the selective down-regulation of the cyclo-oxygenase (COX)-2-mediated cytokine-induced secretion of prostaglandin E2 (PGE2). This inhibitory action has been associated with reduced expression of COX-2, without modulating COX-1 expression. This mechanism is associated with VA-induced destabilization of COX-2 mRNA, thereby depleting the functional COX-2 mRNA available for protein synthesis and for subsequent induction of secretion of PGE2. Together, these results demonstrate a novel anti-inflammatory mechanism of action of VA preparation, wherein VAQUSpez an anti-inflammatory effect by inhibiting cytokine-induced PGE2 via selective inhibition of COX-2 and destabilization of COX-2 mRNA.

[1]  S. Kaveri,et al.  Viscum album-Mediated COX-2 Inhibition Implicates Destabilization of COX-2 mRNA , 2015, PloS one.

[2]  S. Kaveri,et al.  Viscum album Exerts Anti-Inflammatory Effect by Selectively Inhibiting Cytokine-Induced Expression of Cyclooxygenase-2 , 2011, PloS one.

[3]  S. Kaveri,et al.  Intravenous immunoglobulin therapy in rheumatic diseases , 2011, Nature Reviews Rheumatology.

[4]  M. A. Mohd,et al.  In Vitro and In Vivo Anti-Inflammatory Activity of 17-O-Acetylacuminolide through the Inhibition of Cytokines, NF-κB Translocation and IKKβ Activity , 2010, PloS one.

[5]  V. Gerber,et al.  Treatment of clinically diagnosed equine sarcoid with a mistletoe extract (Viscum album austriacus). , 2010, Journal of veterinary internal medicine.

[6]  G. Davies,et al.  Neutralisation of Interleukin-13 in Mice Prevents Airway Pathology Caused by Chronic Exposure to House Dust Mite , 2010, PloS one.

[7]  H. Kiene,et al.  Review Article: Influence of Viscum album L (European Mistletoe) Extracts on Quality of Life in Cancer Patients: A Systematic Review of Controlled Clinical Studies , 2010, Integrative cancer therapies.

[8]  R. Medzhitov.  Inflammation 2010: New Adventures of an Old Flame , 2010, Cell.

[9]  G. Cravotto,et al.  Phytotherapeutics: an evaluation of the potential of 1000 plants , 2010, Journal of clinical pharmacy and therapeutics.

[10]  J. Bayry.  Immunology: TL1A in the inflammatory network in autoimmune diseases , 2010, Nature Reviews Rheumatology.

[11]  M. Carnero,et al.  Overproduction of cyclo-oxygenase-2 (COX-2) is involved in the resistance to apoptosis in vascular smooth muscle cells from diabetic patients: a link between inflammation and apoptosis , 2010, Diabetologia.

[12]  A. Pozzi,et al.  Regulation of endothelial cell functions by basement membrane‐ and arachidonic acid‐derived products , 2009, Wiley interdisciplinary reviews. Systems biology and medicine.

[13]  S. Kaveri,et al.  Antiangiogenic properties of viscum album extracts are associated with endothelial cytotoxicity. , 2009, Anticancer research.

[14]  Jagadeesh Bayry,et al.  Novel cellular and molecular mechanisms of induction of immune responses by aluminum adjuvants. , 2009, Trends in pharmacological sciences.

[15]  L. Marnett.  The COXIB experience: a look in the rearview mirror. , 2009, Annual review of pharmacology and toxicology.

[16]  Alain Friboulet,et al.  Induction of maturation and activation of human dendritic cells: A mechanism underlying the beneficial effect of Viscum album as complimentary therapy in cancer , 2008, BMC Cancer.

[17]  S. Kaveri,et al.  Rescuing CD4+CD25+ regulatory T-cell functions in rheumatoid arthritis by cytokine-targeted monoclonal antibody therapy. , 2007, Drug discovery today.

[18]  S. Kaveri,et al.  Molecular Mechanisms Underlying the Immunomodulatory Effects of Mistletoe (Viscum album L.) Extracts Iscador , 2006, Arzneimittelforschung.

[19]  K. Urech,et al.  Viscotoxins, Mistletoe Lectins and their Isoforms in Mistletoe (Viscum album L.) Extracts Iscador , 2006, Arzneimittelforschung.

[20]  S. Kaveri,et al.  Interleukin-12 is associated with the in vivo anti-tumor effect of mistletoe extracts in B16 mouse melanoma. , 2006, Cancer letters.

[21]  L. Heinzerling,et al.  Immunologic Effector Mechanisms of a Standardized Mistletoe Extract on the Function of Human Monocytes and Lymphocytes in vitro, ex vivo, and in vivo , 2006, Journal of Clinical Immunology.

[22]  M. Radenković,et al.  Neurophysiological effects of mistletoe (Viscum album L.) on isolated rat intestines , 2006, Phytotherapy research : PTR.

[23]  J. van Hattum,et al.  Exploratory study on the effects of treatment with two mistletoe preparations on chronic hepatitis C. , 2011, Arzneimittel-Forschung.

[24]  Walter E. Friedelb.  Wirksamkeit und Sicherheit der komplementären Langzeitbehandlung mit einem standardisierten Extrakt aus Europäischer Mistel (Viscum album L.) zusätzlich zur konventionellen adjuvanten onkologischen Therapie bei primärem, nicht metastasiertem Mammakarzinom , 2004 .

[25]  J. Pelletier,et al.  Cyclooxygenase-2 and prostaglandins in articular tissues. , 2003, Seminars in arthritis and rheumatism.

[26]  S. Kaveri,et al.  Comparative Study of the Sensitivity of Lymphoblastoid and Transformed Monocytic Cell Lines to the Cytotoxic Effects of Viscum album Extracts of Different Origin , 2003, Chemotherapy.

[27]  S. Chrubasik,et al.  Treatment of low back pain with a herbal or synthetic anti-rheumatic: a randomized controlled study. Willow bark extract for low back pain. , 2001, Rheumatology.

[28]  S. Kaveri,et al.  Variable Sensitivity of Lymphoblastoid Cells to Apoptosis Induced by Viscum album Qu FrF, a Therapeutic Preparation of Mistletoe Lectin , 2001, Chemotherapy.

[29]  J. Meyer-Kirchrath,et al.  Cyclooxygenase-2 inhibition and side-effects of non-steroidal anti-inflammatory drugs in the gastrointestinal tract. , 2000, Current medicinal chemistry.

[30]  P. Kam,et al.  Cyclo‐oxygenase isoenzymes: physiological and pharmacological role , 2000, Anaesthesia.

[31]  A. Büssing,et al.  Apoptosis-inducing properties of Viscum album L. extracts from different host trees, correlate with their content of toxic mistletoe lectins. , 1999, Anticancer research.

[32]  E. Kaegi.  Unconventional therapies for cancer: 2. Green tea. The Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative. , 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[33]  A. Morrison,et al.  Antioxidants Inhibit Interleukin-1-induced Cyclooxygenase and Nitric-oxide Synthase Expression in Rat Mesangial Cells , 1996, The Journal of Biological Chemistry.

[34]  G. Engelhardt,et al.  Distinct isoforms (COX‐1 and COX‐2) of cyclooxygenase: possible physiological and therapeutic implications , 1996, Fundamental & clinical pharmacology.

[35]  R. Herrmann,et al.  A plant lectin derived from Viscum album induces cytokine gene expression and protein production in cultures of human peripheral blood mononuclear cells. , 1995, Natural immunity.

[36]  B. Ramot,et al.  Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity. , 1983, Clinical and experimental immunology.

[37]  F. Stirpe,et al.  Isolation and characterization of viscumin, a toxic lectin from Viscum album L. (mistletoe). , 1982, The Journal of biological chemistry.

[38]  H. Franz,et al.  Isolation and properties of three lectins from mistletoe (Viscum album L.). , 1981, The Biochemical journal.